Sep 19, 2022
1:10
For every 10 shares held, investors received 1. The price per share adjusted from $7.35 to $73.49.
The split itself did not change the total investment value.
Syros Pharmaceuticals, Inc. (OTC:SYRS) operates in the Pharmaceuticals: major industry.
Syros Pharmaceuticals, Inc. company overviewSyros Pharmaceuticals, Inc.'s most recent stock split was on September 19, 2022. It was a 1-for-10 reverse split, so shareholders received 1 share for every 10 they held.
Syros Pharmaceuticals, Inc. has split its stock once. This history records one reverse split, on September 19, 2022.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Syros Pharmaceuticals, Inc.'s 1-for-10 reverse split on September 19, 2022, every 10 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Syros Pharmaceuticals, Inc. has not announced a new split in our records. Its most recent split was on September 19, 2022, 4 years ago. Companies announce splits in advance, and any new OTC:SYRS split will appear on this page.